IDEXX > Equine Health > SURPASS > Overview
 
 

SURPASS logoSURPASS® (1% diclofenac sodium) Topical
Anti-Inflammatory Cream for Use in Horses
Treatment of Lameness and Pain Management in Horses



 

Introducing SURPASS® (1% diclofenac sodium) Topical Anti-Inflammatory Cream for Use in Horses

Why treat the whole horse when you can simply treat the joint?

Target pain precisely with SURPASS (1% diclofenac sodium) Topical Anti-Inflammatory Cream—a unique formulation you can apply exactly where it's needed. It employs a totally new technology not based on traditional carriers like DMSO and PLO gel. Horses treated twice daily with SURPASS for five days showed a significant improvement in lameness scores.

SCIENTIFIC PROOF
SURPASS (1% diclofenac sodium) Topical Anti-Inflammatory Cream
generated significant improvement in lameness scores in a double-blind, placebo-controlled multi-centric clinical field study. 1

Note: Horses should undergo a thorough history and physical examination before initiation of NSAID therapy. Owners should be advised to observe for signs of potential drug toxicity. As a class, NSAIDs may be associated with gastrointestinal and renal toxicity.



Now available through your authorized IDEXX distributor
.
SURPASS (1% diclofenac sodium) Topical Anti-Inflammatory Cream is sold in boxes of six tubes. One tube will treat one horse for ten days.

 
Just Released:
IDEXX-sponsored roundtable, Managing Equine Joint Inflammation, results published in Compendium Equine. (2.5 MB)
 
Package Insert (704 KB)
Material Safety Data Sheet (72 KB)
 
For more information on SURPASS® (1% diclofenac sodium) Topical Anti-Inflammatory Cream, call IDEXX Customer Support at 1-800-374-8006.
 

Testimonials
"One case I treated was a horse with chronic joint inflammation that did not respond to injected treatments. SURPASS helped her tremendously. I have also used SURPASS in horses that did not respond to other treatments or that have sensitivities or reactions to other treatments."

Dr. Andrew Roberts
Read the full testimonial

SURPASS Ad

 
1   In a clinical field study, SURPASS-treated horses showed significant improvement in lameness scores based on daily ratings by field study investigators. Data submitted to FDA and on file, IDEXX Pharmaceuticals, Inc.
 

This symbol indicates PDF-formatted materials. To view, you may need to download a free copy of Adobe® Reader® software.

 
© 2008 IDEXX Laboratories, Inc.
All rights reserved.